The University of Chicago Medicine Comprehensive Cancer Center (UCCCC) integrates and centralizes cancer-focused educational and professional development activities across the University of Chicago. The UCCCC actively supports the training and career development of the next-generation of cancer researchers. The programming and activities of the UCCCC Cancer Research Career Enhancement and Related Activities Core engage trainees at all levels (high school, undergraduate, graduate/medical student, postdoctoral, faculty, and healthcare professionals in our community), especially those from populations underrepresented in the biomedical sciences and cancer research. This is especially important in the communities that we serve on the South Side of Chicago. Our long-term goal is to innovate in the development and integration of career enhancement activities for trainees to support their cancer-focused career success and the development of a robust and diverse cancer research workforce. We accomplish this goal with the following Specific Aims: 1) To provide pipeline programming for high school and undergraduate students to encourage students, including those from backgrounds underrepresented in the biomedical sciences, to explore careers in cancer research and/or medicine; 2) To provide integrated, multidisciplinary cancer research training opportunities for graduate students, combined MD/PhD trainees, and medical students; 3) To provide career enhancement activities for postgraduate fellows and faculty at all levels; and 4) To provide professional development activities for community partners, including healthcare professionals. The UCCCC serves as the coordinating body for activities of cancer-based training and mentoring programs at all levels across the University of Chicago Medicine and Biological Sciences Division (BSD), leveraging existing infrastructure and addressing training gaps. Specific strengths and unique aspects of this Core are: 1) A multifaceted approach to support aspiring and established researchers across their career trajectory; 2) Strong partnerships among key institutions on Chicago?s South Side, including institutions of higher learning and diverse high schools; and 3) An exceptional leadership and mentoring team of highly dedicated, passionate, and experienced individuals to execute the programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-45
Application #
9904501
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications